Keyphrases
Canine Hemangiosarcoma
100%
Endothelial Cells
100%
Tumor Growth
100%
Angiogenesis
100%
Interleukin-12 (IL-12)
100%
Xenograft Model
100%
Inhibit Tumor
100%
Cell Growth
25%
Malignancy
25%
In Cancer
25%
Interleukin-8
25%
Tumor Cells
25%
Integrin
25%
Growth Factors
25%
Hemangiosarcoma
25%
Xenograft
25%
Vascular Endothelial Growth Factor Receptor (VEGFR)
25%
Cancer Therapy
25%
Immunomodulatory Effect
25%
Endothelium
25%
Antiangiogenic Agents
25%
Antiangiogenic
25%
Vascular Endothelial Growth Factor
25%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
25%
Immunodeficient Mice
25%
CD31
25%
Basic Fibroblast Growth Factor (bFGF)
25%
Renewable Sources
25%
Spontaneous Tumors
25%
CD146
25%
Tumor Mass
25%
Vascular Channels
25%
Fibroblast Growth Factor 8
25%
Angiogenic Response
25%
XID Mice
25%
Antiangiogenic Activity
25%
Medicine and Dentistry
Angiosarcoma
100%
Tumor Progression
100%
Xenograft
100%
Endothelial Cell
100%
Angiogenesis
100%
Interleukin 12
100%
Neoplasm
50%
Cytokine
50%
Cell Line
50%
Cell Growth
25%
Cancer Therapy
25%
Cancer
25%
Tumor Cell
25%
Antiangiogenic Activity
25%
Vasculotropin
25%
Biopsy Technique
25%
Angiogenesis Inhibitor
25%
Interleukin 8
25%
Fibroblast Growth Factor 2
25%
Vasculotropin Receptor 2
25%
Fibroblast Growth Factor 8
25%
Vasculotropin Receptor 1
25%
Antiangiogenic
25%
Growth Factor
25%
Integrin
25%
Immunology and Microbiology
Xenograft
100%
Angiogenesis
100%
Interleukin 12
100%
Cell Line
66%
Vasculotropin
66%
Cytokine
66%
Growth Factor
33%
Antiangiogenic Activity
33%
Tumor Cell
33%
CD31
33%
Fibroblast Growth Factor 2
33%
Fibroblast Growth Factor 8
33%
Cell Growth
33%
Angiogenesis Inhibitor
33%
Interleukin 8
33%
Integrin
33%
Veterinary Science and Veterinary Medicine
Neoplasm
100%
Canine Hemangiosarcoma
100%
Mouse
60%
Vascular Endothelial Growth Factor
40%
Cancer
40%
Dog
20%
Growth Factor
20%
Basic Fibroblast Growth Factor
20%
Angiosarcoma
20%